Beyond BYON 深 沪
等待开盘 09-17 09:30:00 美东时间
9.44
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.44
- 总市值 5.42亿
- 52周最高 12.24
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.54
- 委 比 0.00%
- 总股本 5740.60万
- 历史最高 37.10
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.54
- 每 手 1
- 风险率 7.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
SAN FRANCISCO, Sept. 16, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a c...
今天 06:09
Breaking Down Unum Gr: 11 Analysts Share Their Views
11 analysts have shared their evaluations of Unum Gr (NYSE:UNM) during the rece...
今天 06:01
The Analyst Verdict: Hewlett Packard In The Eyes Of 19 Experts
Hewlett Packard (NYSE:HPE) underwent analysis by 19 analysts in the last quarte...
今天 05:00
Beyondspring Shareholders Ratify Accounting Firm Appointment
The latest announcement is out from Beyondspring ( ($BYSI) ). BeyondSpring Inc....
今天 04:36
Beyond The Numbers: 4 Analysts Discuss Dave & Buster's Enter Stock
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
今天 03:03
Where nVent Electric Stands With Analysts
Throughout the last three months, 8 analysts have evaluated nVent Electric (NYS...
今天 02:02
Penelope Bourbon Announces Partnership with FCancer
Collaboration marks largest co-branded whiskey release yet and over $500,000 donation LOS ANGELES, Sept. 16, 2025 /PRNewswire/ -- Penelope Bourbon, one of the fastest-growing award-winning p...
今天 00:58
Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
ARC Resources declares $0.19 dividend
ARC Resources (TSX:ARX:CA) declares $0.19/share quarterly dividend. Forward yield 3.1% Payable Oct. 15; for shareholders of record Sept. 29; ex-div Sept. 29. See ARX:CA Dividend Scorecard, Yield Chart...
09-16 21:55
MIRA Pharmaceuticals Reports Ketamir-2 Restored Normal Behavior In PTSD Animal Study, Expands Focus Beyond Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced
09-16 19:37
